Torrent Pharmaceuticals Limited CEO Net Worth

Last Updated Mar 10, 2025
CEO NameSamarjeet Satya.
NationalityIndia
Net Worth Estimation$2 million

Samarjeet Satya, current CEO of Torrent Pharmaceuticals Limited, is estimated to have a net worth of around $2 million, primarily derived from his executive compensation, stock holdings, and performance-based incentives within the company. His financial profile is significantly lower than the company's promoter families, reflecting his status as a professional manager rather than a majority stakeholder.

Samarjeet Satya's estimated net worth of $2,000,000 is only 0.4% of the maximum ($500,000,000) and 20% of the minimum ($10,000,000) estimated CEO net worths in the pharmaceutical sector. This places him significantly below the typical range for CEOs in this business category.

Business Category: Pharmaceutical

Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 500000000 USD


Samarjeet Satya. Performance in Torrent Pharmaceuticals Limited

Samarjeet Satya, CEO of Torrent Pharmaceuticals Limited, demonstrates visionary leadership with a strong focus on strategic decision-making that aligns with the company's growth objectives. His data-driven approach and stakeholder collaboration have enhanced operational efficiency and expanded the company's global footprint. Under his leadership, Torrent Pharmaceuticals has achieved significant performance improvements, including increased market share and robust financial results.


Latest News

Torrent Pharmaceuticals appoints Aman Mehta as Managing Director amid strategic growth and acquisitions

Torrent Pharmaceuticals is undergoing a generational leadership transition with Aman Mehta, son of Chairman Samir Mehta, appointed Managing Director from August 1, 2025. Under his leadership, the company is focusing on specialty markets, operational excellence, and has recently acquired a significant stake in JB Chemicals, positioning itself as India's 5th largest drugmaker with robust revenue growth in domestic and international markets.
Source: http://timesofindia.indiatimes.com/city/ahmedabad/aman-mehta-to-lead-torrent-pharma-in-generational-transition/articleshow/121294727.cms



Disclaimer.
The information provided in this document is for general informational purposes only and is not guaranteed to be complete. While we strive to ensure the accuracy of the content, we cannot guarantee that the details mentioned are up-to-date or applicable to all scenarios. Topics about Torrent Pharmaceuticals Limited are subject to change from time to time.

Comments

No comment yet